BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4408388)

  • 21. Thyrotropin alters the utilization of thyroglobulin's hormonogenic sites.
    Fassler CA; Dunn JT; Anderson PC; Fox JW; Dunn AD; Hite LA; Moore RC; Kim PS
    J Biol Chem; 1988 Nov; 263(33):17366-71. PubMed ID: 3182849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of proteolysis in the mouse thyroid gland by thyrotropin and the long-acting thyroid stimulator: comparison of intact lobe and homogenate.
    Konno N; Murthy PV; McKenzie JM
    Endocrinology; 1970 Nov; 87(5):1062-8. PubMed ID: 5482934
    [No Abstract]   [Full Text] [Related]  

  • 23. Thyroid physiology and functional tests.
    Zellmann HE
    Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroid antibodies and protein-binding of thyroxine in patients with and without thyrotoxicosis.
    Bános C; Takó J; Györgyi S; Juhász J; Sztraka I; Kapus I
    Endokrinologie; 1973 Jan; 61(1):32-6. PubMed ID: 4633897
    [No Abstract]   [Full Text] [Related]  

  • 25. Thyroglobulin-like substances with low iodine content in the serum of patients receiving antithyroid therapy.
    Hjort T; Lauridsen UB; Persson I
    J Clin Endocrinol Metab; 1970 Apr; 30(4):520-3. PubMed ID: 5435289
    [No Abstract]   [Full Text] [Related]  

  • 26. Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.
    Fukuchi M; Matsuoka T; Inoue T; Miyai K; Kumahara Y
    Acta Endocrinol (Copenh); 1970 Dec; 65(4):577-82. PubMed ID: 5536685
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED; Dentinger M
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
    Kendall-Taylor P
    Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroidal phospholipogenesis.
    Burke G
    Endocrinology; 1968 Dec; 83(6):1210-6. PubMed ID: 5721994
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects.
    Torres MS; Ramirez L; Simkin PH; Braverman LE; Emerson CH
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1660-4. PubMed ID: 11297600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-acting thyroid stimulator.
    Munro DS
    Curr Top Exp Endocrinol; 1971; 1():175-98. PubMed ID: 4350824
    [No Abstract]   [Full Text] [Related]  

  • 32. THE EFFECT OF THYROID HORMONE ON THE LEVELS OF THYROTROPIN (TSH) AND LONG-ACTING THYROID STIMULATOR (L.A.T.S.) IN THYROID DISORDERS.
    SAKAGAMI A; FUKUCHI M; MASUI H; MIYAI K; IWATSUBO H; KUMAHARA Y; YOSHIDA T
    Med J Osaka Univ; 1964 Mar; 14():235-44. PubMed ID: 14195720
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyroid antibodies and hypothyroidism in 131-I therapy for hyperthyroidism.
    Lundell G; Jonsson J
    Acta Radiol Ther Phys Biol; 1973 Oct; 12(5):443-53. PubMed ID: 4777976
    [No Abstract]   [Full Text] [Related]  

  • 34. [Improved evaluation criteria of autonomous thyroid adenoma: triiodothyronine concentration in serum, functional definition through TRH test].
    Wenzel KW; Meinhold H; Schleusener H; Botsch H
    Dtsch Med Wochenschr; 1974 Jul; 99(27):1465-73. PubMed ID: 4135676
    [No Abstract]   [Full Text] [Related]  

  • 35. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F; Schleusener H; Uher L; Ananos A
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
    Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
    Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.
    Shishiba Y; Solomon DH; Beall GN
    Endocrinology; 1967 May; 80(5):957-61. PubMed ID: 6023563
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on thyroid stimulating hormone and the long-acting thyroid stimulating hormone.
    Bitensky L; Alaghband-Zadeh J; Chayen J
    Clin Endocrinol (Oxf); 1974 Jul; 3(3):363-74. PubMed ID: 4837956
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of response to TSH injections in euthyroid patients with high LATS levels.
    Adams DD; Couchman K; Kilpatrick JA
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1502-3. PubMed ID: 5349725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.